Ambroxol Hydrochloride

盐酸氨溴索

Report date: 2026/04/22 20:01:10
NME

Base Information

Drug NameAmbroxol Hydrochloride
Drug Alias Name盐酸氨溴素Ambroxol SR盐酸溴环已胺醇ZivaAmbroxolum +[29
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsSodium channel alpha subunit
Therapy Area/IndicationsGaucher's disease type IPainAmyotrophic Lateral Sclerosis +[16
Global Approved IndicationsRespiratory Tract DiseasesPharyngitisBronchitis
Approved Indications in ChinaRespiratory Tract Diseases
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[12
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Active IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease +[14
Inactive IndicationsGaucher's disease type IPain

Other Information

ATC CodeR05CB06